ElastiMed Welcomes Dr. Antonios Gasparis to its Medical AdvisoryBoard

YOKNEAM ILIT, Israel, Dec. 29, 2025 – ElastiMed Ltd., developer of MyoSleeve, the cable-free EAP-powered
wearable compression device for lymphedema and venous disease, today announced that Dr. Antonios Gasparis,
MD, FACS, has joined its Medical Advisory Board.

Dr. Gasparis is System Chief for Venous Diseases at Northwell Health and previously spent two decades on faculty
at Stony Brook University, where he founded and directed the Center for Vein Care and served as Professor of
Surgery. He is a Past President of the American Venous Forum, the leading national society dedicated to venous and

Dr. Antonios Gasparis

lymphatic disease, and has authored more than 80 peer-reviewed publications on venous and lymphatic conditions.
His clinical and research focus spans minimally invasive venous therapy, lymphedema management, and the
development of new treatment pathways for chronic venous disease.

Dr. Gasparis joins ElastiMed’s advisory panel alongside other leaders in the venous and lymphatic field, contributing clinical and scientific guidance to the company’s ongoing studies of MyoSleeve, including its
multi-site US clinical program in lymphedema.

“Dr. Gasparis is one of the most respected voices in venous and lymphatic disease, and his perspective will be
instrumental as we generate the clinical evidence base for MyoSleeve” said Omer Zelka, Founder and CEO of
ElastiMed. “Having someone with his depth of surgical and research experience on our advisory board
strengthens both our science and our credibility with the clinical community.”

“Patients with lymphedema and venous disease have long been underserved” said Dr. Gasparis. “ElastiMed”s
cable-free approach is a genuinely different way to deliver compression therapy, and I look forward to supporting the team as they build out the clinical data behind it.”


About ElastiMed

ElastiMed Ltd. is the developer of MyoSleeve, an FDA-cleared, cable-free wearable compression device powered
by electroactive polymer (EAP) technology, designed to treat lymphedema and venous conditions. Founded in 2015 and headquartered in Yokneam Ilit, Israel.

Send us a message

Great! We’ve received your information.